Proof of leadership

Already live where
the market is going.

Not projections — production. The evidence a buying committee, a QA organization, or a regulator can check for themselves.

Страны, где работает приложение ePI by PharmaLedger

с 2023 года

Языки, на которых приложение ePI предоставляет утверждённую информацию

Партнёры-основатели из фармы, технологий, науки и пациентских организаций

12 глобальных фармкомпаний

Объединены открытые стандарты: GS1 Digital Link, EU DPP, EPCIS 2.0

Работают в сети

Documented publicly

ISPE Pharma 4.0 Baseline Case Study No. 237

The ePI implementation journey — proof-of-concepts, TRL 7 assessment, 300+ validation users, and the April 2023 production launch — is published through ISPE, not just claimed here.

Read the case study →Regulated environments

Compliance you can inspect, not just cite

GxP-aware platform, 21 CFR Part 11 posture, tamper-evident audit trail — with the live platform status published openly in the Trust Center.

Open the Trust Center →Standards-led

Built on the standards the market is converging on

GS1 Digital Link, EPCIS 2.0, the EU Digital Product Passport, and ePI on HL7 FHIR — implemented in production, connected to your existing systems rather than replacing them.

Explore the standards →Enterprise qualification

Supplier-qualified for regulated pharma

Enterprise qualification proof is available for approved sales conversations.

Request a consultation →

See it yourself

Every major claim here links to a source: production evidence, association governance, status history, architecture reference, or a controlled document.

Bring your QA lead, your architect, or your regulatory team. 30 minutes, no procurement, no NDA.

Book a consultation →